A Divalent Major Histocompatibility Complex/IgG1 Fusion Protein Induces Antigen-Specific T Cell Activationin Vitroandin Vivo

This publication has 32 references indexed in Scilit:

• CONTRASTING IN VIVO EFFECTS ON T HELPER CELL FUNCTIONS INDUCED BY MITOGENIC (INTACT) VERSUS NONMITOGENIC (F(abʼ2) ANTI-CD3 MONOCLONAL ANTIBODY
  Transplantation, 1995
• IMMUNOMODULATION BY SOLUBLE HLA CLASS I
  Transplantation, 1995
• Reduction of mortality and lymphadenopathy in mrl‐lpr/lpr mice treated with nonmitogenic anti‐cd3 monoclonal antibody
  Arthritis & Rheumatism, 1994
• INDUCTION OF SPECIFIC UNRESPONSIVENESS TO CARDIAC ALLOGRAFTS BY SHORT-TERM ADMINISTRATION OF ANTI T CELL RECEPTOR αβ ANTIBODY1
  Transplantation, 1994
• T cell receptor antagonist peptides induce positive selection
  Cell, 1994
• Peptide variants reveal how antibodies recognize major histocompatibility complex class I
  European Journal of Immunology, 1993
• The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the K^b‐restricted ovalbumin determinant
  European Journal of Immunology, 1990
• PROPHYLACTIC USE OF OKT3 MONOCLONAL ANTIBODY IN CADAVER KIDNEY RECIPIENTS UTILIZATION OF OKT3 AS THE SOLE IMMUNOSUPPRESSIVE AGENT
  Transplantation, 1986
• Fc receptors on monocytes cause OKT3-treated lymphocytes to internalize T3 and to secrete IL-2
  Cellular Immunology, 1986
• EVOLVING USE OF OKT3 MONOCLONAL ANTIBODY FOR TREATMENT OF RENAL ALLOGRAFT REJECTION
  Transplantation, 1984